 Chariot Oil & Gas Limited
Annual Report & Accounts 2010
14
Remuneration Committee
The Group's Remuneration Committee comprises of Peter Kidney (Chairman), Robert Sinclair and Adonis Pouroulis.
The purpose of the Remuneration Committee is to:
make recommendations to the Board on an overall remuneration policy for Executive Directors and other senior executives   	
in order to retain, attract and motivate high quality executives capable of achieving the Group's objectives; and
demonstrate to shareholders that the remuneration of the Executive Directors of the Group is set by a committee whose  	
members have no personal interest in the outcome of their decision, and who will have due regard to the interests of  
the shareholders.
Procedures for developing policy and fixing remuneration
The Board fixes executive remuneration and ensures that no Director is involved in deciding his or her own remuneration.  
The Committee is authorised to obtain outside professional advice and expertise.
The Remuneration Committee is authorised by the Board to investigate any matter within its terms of reference. It is authorised 
to seek any information that it requires from any employee.
Details of the remuneration policy
The basic fees to be paid to the directors are recommended by the Remuneration Committee, and are subject to approval by 
the full Board.
Directors' service agreements
All service agreements for directors are terminable by either party on six months' notice.
Directors' remuneration
The following remuneration comprising directors' fees, share option charge and benefits in kind, were payable to directors during 
the year:
 
  Performance    
 Fees/ cash Share option Benefits Pension 2010 2009
 basic salary bonus valuation
(2)
 in kind
(1)
 contribution Total Total
 US$'000 US$'000 US$'000 US$'000 US$'000 US$'000 US$'000
P Welch 188 - 125 1 - 314 -
K Broger
(4)
 238 - - 2 - 240 638
J Burgess 219 49 - - 4 272 350
A Pouroulis 71 - - - - 71 201
P Kidney 275
(3)
 - - - - 275 968
R Sinclair 20 - - - - 20 146
N Leighton
(4)
 14 - - - - 14 148
H Ndume 150 - - 6 - 156 459
Total 1,175 49 125 9 4 1,362 2,910
1 Benefits typically comprise private health care arrangements and permanent health insurance.
 Pension costs in 2009 in relation to Directors were US$4,000 (2009: US$ nil).
2  The IFRS 2, share option valuation charge relating to the Directors is US$125,000 (non-cash) (2009: US$2,175,000, of which US$368,000 worth have 
been reversed from the share-based payment reserve due to Kevin Broger's options lapsing upon his resignation).
3 Includes US$204,000 for additional services during the year including work on the HRT contract dispute.
4 Directors who resigned during the year.
Directors' interests in shares
The Directors who held office at the end of the year had the following interests in the issued share capital of the Group.
 
      2010 2009
P Welch      - -
J Burgess      2,250,000 2,250,000
A Pouroulis
(1)
      22,835,971 22,835,971
P Kidney      500,000 500,000
R Sinclair      - -
H Ndume
(2)
      2 1,376, 171 22,37 6,1 7 1
Total      47 ,963,592 48,963,592
1 Shares are held by Westward Investments Limited a Company which is owned by a discretionary trust of which A Pouroulis is one of a number of beneficiaries.
2 Shares are held by Protech Namibia (Pty) Limited of which H Ndume is the sole registered shareholder.
Directors' Remuneration Report Chariot Oil & Gas Limited
Annual Report & Accounts 2010
15
Corporate Governan Ce Share options
The Group operates a share option scheme pursuant to which Directors and senior executives may be granted options to 
acquire ordinary shares in the Company at a fixed option exercise price. During the year, options were granted over a total of 
4,000,000 ordinary shares.
Further details of the above share option scheme and long-term incentive plan can be found in note 20.
Directors' share options
The Directors who held office at the end of the financial year had the following interests in the share option scheme:
 
  Options  Options
  held at  Options held at
  1st March  granted 28th February Exercise Exercisable
  2009  in the year  2010 price (p) from Expiry date
P Welch  - 3,000,000 3,000,000 26.00 1 3 / 11 /2 0 11 1 3 / 11 /2 0 1 9
J Burgess  200,000 - 200,000 130.00 1 3/05/20 10 1 3/05/20 18
A Pouroulis  100,000 - 100,000 130.00 1 3/05/20 10 1 3/05/20 18
P Kidney  500,000 - 500,000 38.50 25/04/20 10 25/04/20 1 8
R Sinclair  100,000 - 100,000 130.00 1 3/05/20 10 1 3/05/20 18
H Ndume  250,000 - 250,000 130.00 1 3/05/20 10 1 3/05/20 18
Total  1,150,000 3,000,000 4,150,000 
No options were exercised during the year. Kevin Broger's 300,000 options were cancelled upon his resignation on 15 June 
2009. Norman Leighton resigned on 10th October 2009, and he may exercise 100,000 options at a price of  1.30 per share, at 
the discretion of the Board. 
The interests of the Directors to subscribe for ordinary shares have not changed since the year end.
Significant shareholders
Westward Investments Limited       16.1%
Protech Namibia (Pty) Limited       15.1%
Citigroup       13.3%
Generali       5.6%
Baillie Gifford       5.1%
Libra Advisors       4.5%
Approximate percentage of ordinary shares not in public hands: 34 per cent.
By order of the Board
Peter Kidney 
Chairman of the Remuneration Committee